![Ana Teresa Freitas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ana Teresa Freitas
Chief Executive Officer at HeartGenetics, Genetics & Biotechnology SA
Profile
Ana Teresa Freitas is associated with HeartGenetics, Genetics & Biotechnology SA as the Chief Executive Officer since 2013.
She is the founder of the company, which was also founded in 2013.
Ana Teresa Freitas active positions
Companies | Position | Start |
---|---|---|
HeartGenetics, Genetics & Biotechnology SA
![]() HeartGenetics, Genetics & Biotechnology SA Miscellaneous Commercial ServicesCommercial Services HeartGenetics, Genetics & Biotechnology SA operates as a biotech company that develops genetic tests and computational tools designed to support clinical diagnosis and the prevention of cardiovascular diseases. Its genetic testing kits include Clopidogrel PGX, TromboGene Kit, Warfarin PGX, Simvastatin PGX, and DNArterial Kit. The company was founded by Ana Teresa Freitas and Susana Santos in April 2013 and is headquartered in Cantanhede, Portugal. | Chief Executive Officer | 2013-03-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
HeartGenetics, Genetics & Biotechnology SA
![]() HeartGenetics, Genetics & Biotechnology SA Miscellaneous Commercial ServicesCommercial Services HeartGenetics, Genetics & Biotechnology SA operates as a biotech company that develops genetic tests and computational tools designed to support clinical diagnosis and the prevention of cardiovascular diseases. Its genetic testing kits include Clopidogrel PGX, TromboGene Kit, Warfarin PGX, Simvastatin PGX, and DNArterial Kit. The company was founded by Ana Teresa Freitas and Susana Santos in April 2013 and is headquartered in Cantanhede, Portugal. | Commercial Services |
- Stock Market
- Insiders
- Ana Teresa Freitas